WS #12353

From 500 msgs · 12 key-dev
Holding: newest synthesis is 122d 4h old

Abbott reports solid Q2 beat-and-raise with revenue up 13% YoY, driven by Medical Devices and Cancer Diagnostics; raises FY26 EPS guidance.

Abbott Laboratories Q2 Beat-and-Raise

Abbott reports solid Q2 beat-and-raise with revenue up 13% YoY, driven by Medical Devices and Cancer Diagnostics; raises FY26 EPS guidance.

Full world state #12353 →